Cue Biopharma (CUE) Stock Chart & Stock Price History → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CUE Stock Alerts $1.91 +0.20 (+11.70%) (As of 01:20 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Cue Biopharma Stock Price Performance5 Day Performance+16.46%1 Month Performance+22.44%3 Month Performance-8.17%6 Month Performance-21.72%Year-To-Date Performance-27.65%1 Year Performance-54.52% Receive CUE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Huge Alerts**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report CUE Stock Chart for Monday, May, 20, 2024 CUE Chart by TradingView Cue Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$1.74$1.71-1.72%$1.77$1.66117,895 shs$83.17 million05/16/2024$1.64$1.74+6.10%$1.86$1.63278,355 shs$84.63 million05/15/2024$1.55$1.64+5.81%$1.67$1.53263,499 shs$79.77 million05/14/2024$1.65$1.55-6.06%$1.74$1.54614,488 shs$80.26 million05/13/2024$1.74$1.65-5.17%$1.83$1.6598,111 shs$80.26 million05/10/2024$1.92$1.74-9.14%$1.99$1.62448,299 shs$84.64 million Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$1.91$1.92+0.26%$1.98$1.84171,338 shs$93.15 million05/08/2024$2.18$1.91-12.39%$2.13$1.84261,072 shs$92.90 million05/07/2024$2.08$2.18+4.81%$2.20$2.08237,223 shs$106.04 million05/06/2024$2.13$2.08-2.35%$2.26$2.05319,285 shs$101.17 million05/03/2024$1.88$2.13+13.30%$2.19$1.87663,090 shs$103.60 million05/02/2024$1.91$1.88-1.31%$1.94$1.76226,091 shs$91.44 million05/01/2024$1.90$1.91+0.26%$1.97$1.60622,040 shs$92.66 million04/30/2024$1.42$1.90+33.80%$1.98$1.371.26 million shs$92.42 million04/29/2024$1.37$1.42+4.03%$1.48$1.38155,919 shs$69.07 million04/26/2024$1.41$1.37-3.19%$1.44$1.32263,686 shs$66.39 million04/25/2024$1.42$1.41-0.70%$1.42$1.30169,155 shs$68.59 million04/24/2024$1.50$1.42-5.33%$1.54$1.38319,351 shs$69.07 million04/23/2024$1.57$1.50-4.46%$1.60$1.49161,329 shs$72.96 million04/22/2024$1.56$1.57+0.64%$1.58$1.49181,252 shs$76.37 million04/19/2024$1.58$1.56-1.27%$1.61$1.52169,010 shs$75.88 million04/18/2024$1.63$1.58-3.07%$1.65$1.56169,208 shs$76.85 million04/17/2024$1.50$1.63+9.03%$1.64$1.50315,315 shs$79.28 million04/16/2024$1.60$1.50-6.27%$1.67$1.47286,850 shs$72.72 million04/15/2024$1.75$1.60-8.86%$1.77$1.57238,986 shs$77.59 million04/12/2024$1.76$1.75-0.57%$1.76$1.65343,510 shs$85.12 million04/11/2024$1.78$1.76-0.85%$1.85$1.66429,855 shs$85.61 million04/10/2024$1.90$1.78-6.58%$1.90$1.72244,354 shs$86.34 million04/09/2024$2.04$1.90-6.86%$1.96$1.81537,918 shs$92.42 million04/08/2024$1.85$2.04+10.27%$2.08$1.85448,706 shs$99.23 million04/05/2024$1.78$1.85+3.93%$1.85$1.75219,691 shs$89.98 million04/04/2024$1.77$1.78+0.56%$1.87$1.74233,925 shs$86.58 million04/03/2024$1.82$1.77-2.75%$1.84$1.74276,747 shs$86.09 million04/02/2024$1.90$1.82-4.21%$1.95$1.78235,803 shs$82.12 million04/01/2024$1.89$1.90+0.53%$1.94$1.82186,807 shs$85.73 million03/29/2024$1.89$1.89$1.94$1.85192,133 shs$85.28 million03/28/2024$1.84$1.89+2.72%$1.94$1.85192,115 shs$85.28 million03/27/2024$1.84$1.84$1.87$1.76199,224 shs$83.02 million03/26/2024$1.86$1.84-1.08%$1.92$1.81138,251 shs$83.03 million03/25/2024$1.90$1.86-2.11%$1.98$1.83187,551 shs$83.92 millionMust-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story…03/22/2024$1.94$1.90-2.06%$1.99$1.87135,756 shs$85.73 million03/21/2024$1.98$1.94-2.02%$2.01$1.85222,909 shs$87.54 million03/20/2024$1.88$1.98+5.32%$1.99$1.79258,347 shs$89.34 million03/19/2024$1.99$1.88-5.53%$1.96$1.85305,392 shs$84.83 million03/18/2024$2.07$1.99-3.86%$2.08$1.98170,046 shs$89.79 million03/15/2024$2.03$2.07+1.97%$2.08$1.98349,069 shs$93.40 million03/14/2024$2.15$2.03-5.58%$2.23$1.98332,949 shs$91.59 million03/13/2024$1.77$2.15+21.47%$2.20$1.95608,731 shs$97.01 million03/12/2024$1.90$1.77-6.84%$1.92$1.77244,798 shs$79.86 million03/11/2024$1.98$1.90-4.04%$2.04$1.90149,003 shs$85.73 million03/08/2024$1.97$1.98+0.51%$2.05$1.93169,941 shs$89.34 million03/07/2024$1.94$1.97+1.55%$2.02$1.88243,730 shs$88.89 million03/06/2024$1.90$1.94+2.11%$1.99$1.85203,878 shs$87.53 million03/05/2024$2.02$1.90-5.94%$2.06$1.86282,261 shs$85.73 million03/04/2024$2.11$2.02-4.27%$2.09$1.98198,619 shs$91.14 million03/01/2024$2.08$2.11+1.69%$2.23$2.08202,739 shs$95.20 million02/29/2024$2.12$2.08-2.12%$2.16$2.06159,424 shs$93.62 million02/28/2024$2.36$2.12-10.17%$2.36$2.10243,139 shs$95.65 million02/27/2024$2.12$2.36+11.32%$2.37$2.141.23 million shs$106.48 million02/26/2024$2.01$2.12+5.47%$2.16$1.98211,666 shs$95.65 million02/23/2024$2.04$2.01-1.47%$2.04$1.95320,458 shs$90.69 million02/22/2024$2.08$2.04-1.92%$2.12$2.00216,192 shs$92.05 million02/21/2024$2.08$2.08$2.13$2.00142,639 shs$93.85 million02/20/2024$2.19$2.08-5.02%$2.25$2.04323,933 shs$93.85 million02/19/2024$2.19$2.19$2.36$2.17228,400 shs$98.81 million Related Companies: Affimed Stock Price Chart SELLAS Life Sciences Group Stock Price Chart BioXcel Therapeutics Stock Price Chart vTv Therapeutics Stock Price Chart Assembly Biosciences Stock Price Chart Aclaris Therapeutics Stock Price Chart Rallybio Stock Price Chart Jaguar Health Stock Price Chart Hookipa Pharma Stock Price Chart Tempest Therapeutics Stock Price Chart Receive CUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CUE) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestNew Options need New Trading StrategiesNetpicks Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.